Legend Biotech (LEGN) Consolidated Net Income (2019 - 2025)
Historic Consolidated Net Income for Legend Biotech (LEGN) over the last 7 years, with Q3 2025 value amounting to -$38.5 million.
- Legend Biotech's Consolidated Net Income rose 6697.58% to -$38.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$260.0 million, marking a year-over-year decrease of 3391.36%. This contributed to the annual value of -$139240.0 for FY2024, which is 9997.32% up from last year.
- Legend Biotech's Consolidated Net Income amounted to -$38.5 million in Q3 2025, which was up 6697.58% from -$124.2 million recorded in Q2 2025.
- In the past 5 years, Legend Biotech's Consolidated Net Income ranged from a high of $54738.0 in Q4 2024 and a low of -$403.6 million during Q4 2021
- In the last 5 years, Legend Biotech's Consolidated Net Income had a median value of -$91.6 million in 2021 and averaged -$99.6 million.
- As far as peak fluctuations go, Legend Biotech's Consolidated Net Income crashed by 3228891.42% in 2022, and later soared by 13678.48% in 2024.
- Quarter analysis of 5 years shows Legend Biotech's Consolidated Net Income stood at -$403.6 million in 2021, then surged by 66.41% to -$135.6 million in 2022, then surged by 99.89% to -$148806.0 in 2023, then skyrocketed by 136.78% to $54738.0 in 2024, then tumbled by 70356.49% to -$38.5 million in 2025.
- Its Consolidated Net Income stands at -$38.5 million for Q3 2025, versus -$124.2 million for Q2 2025 and -$97.3 million for Q1 2025.